Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse
Alle Filter löschen

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1022C3(10)
  2. 10C6(2)
  3. 10G10(2)
  4. 1121B(10)
  5. 11B11(4)
  6. 12B5(2)
  7. 148C09(10)
  8. 164#(10)
  9. 16D7(10)
  10. 16E7#(10)
  11. 17E6#(10)
  12. 17F3(4)
  13. 18#(2)
  14. 18A5(10)
  15. 1B4(10)
  16. 1D11.16.8(2)
  17. 1H4(10)
  18. 1H7(10)
  19. 2339#(10)
  20. 23F2G(10)
  21. 25D2(2)
  22. 2B8(10)
  23. 2c3(2)
  24. 2D9(2)
  25. 3(10)
  26. 30-H12(10)
  27. 30C10(10)
  28. 30H12(2)
  29. 31#(10)
  30. 320-587(10)
  31. 356A11(2)
  32. 368D04(2)
  33. 3B3(2)
  34. 3B6(10)
  35. 3C10(2)
  36. 3H9(10)
  37. 4A4(2)
  38. 5C8(10)
  39. 5E5#(10)
  40. 5F9-G4(10)
  41. 6(10)
  42. 60(10)
  43. 6A7(2)
  44. 6D6(2)
  45. 7(10)
  46. 70(2)
  47. 7A9(10)
  48. 7C6(4)
  49. 81C6(10)
  50. 8A4(2)
  51. 8D4-8(2)
  52. 8D5(10)
  53. 9H4(10)
  54. A12(10)
  55. A14(10)
  56. A2(10)
  57. A4(10)
  58. ab324(10)
  59. ABI793(2)
  60. Abituzumab(3)
  61. ABM109(2)
  62. Abrezekimab(2)
  63. Abrilumab(3)
  64. Adalimumab Beta(3)
  65. ADCT-301(10)
  66. ADCT-602(2)
  67. ADG 153(2)
  68. Afasevikumab(3)
  69. Afelimomab(2)
  70. Aflibercept(2)
  71. Alacizumab(2)
  72. ALX148(2)
  73. AMG 811(3)
  74. Anrukinzumab(3)
  75. AO-176(2)
  76. ARGX-112(3)
  77. Aselizumab(3)
  78. Asunercept(2)
  79. AT-1501(2)
  80. AT001(3)
  81. Atacicept(2)
  82. ATG 031(2)
  83. Atrosimab(3)
  84. Avizakimab(3)
  85. B122(2)
  86. B6H12(10)
  87. BAK209B11(2)
  88. Baminercept Alfa(2)
  89. Basiliximab(3)
  90. BAT6004(2)
  91. BD0801(2)
  92. Bectumomab(2)
  93. Belimumab(3)
  94. Benralizumab(3)
  95. Benufutamab(3)
  96. Bermekimab(3)
  97. Bersanlimab(3)
  98. Bevacizumab(3)
  99. Bexmarilimab(3)
  100. Bifikafusp Alfa(2)
  101. Bimekizumab(3)
  102. BION 1301(2)
  103. Bivatuzumab(3)
  104. BlySmAb-1.1(10)
  105. Brazikumab(3)
  106. Briakinumab(3)
  107. Briobacept(2)
  108. Brolucizumab(2)
  109. BT-063(3)
  110. Burfiralimab(2)
  111. C17.8(2)
  112. C2_2E12(2)
  113. Camidanlumab(3)
  114. Camoteskimab(3)
  115. Canakinumab(3)
  116. Cantuzumab(2)
  117. CAT-02-106(2)
  118. CAT-2200(3)
  119. CC-90002(3)
  120. CDP484(3)
  121. CDP571(2)
  122. CDX-0125-TEI(2)
  123. Cendakimab(3)
  124. Certolizumab(2)
  125. Clazakizumab(3)
  126. Clivatuzumab(3)
  127. CMAB008(3)
  128. CMB-401(2)
  129. CNTO 607(3)
  130. Conatumumab(3)
  131. Conbercept(2)
  132. CYT-91000(2)
  133. D1(10)
  134. D2(4)
  135. D8P1C1(2)
  136. Daclizumab(3)
  137. Dapirolizumab(2)
  138. DC101(12)
  139. Dectrekumab(3)
  140. Denosumab(3)
  141. Depemokimab(3)
  142. Dilpacimab(2)
  143. DISC0280(3)
  144. DLX521(2)
  145. Dovanvetmab(2)
  146. Dreg-55(10)
  147. Drozitumab(3)
  148. DS-8273a(3)
  149. Dupilumab(3)
  150. Dusigitumab(3)
  151. Duvakitug(3)
  152. E4#(20)
  153. Ebdarokimab(3)
  154. Efalizumab(3)
  155. Efdamrofusp Alfa(2)
  156. Eflimrufusp Alfa(2)
  157. Eftozanermin Alfa(2)
  158. Elsilimomab(2)
  159. Emapalumab(3)
  160. ENA2(10)
  161. Enavatuzumab(3)
  162. Enlimomab(3)
  163. Enokizumab(3)
  164. Epitumomab cituxetan(2)
  165. Epratuzumab(5)
  166. Eptinezumab(3)
  167. Erlizumab(3)
  168. ESBA 105(3)
  169. Etanercept(2)
  170. Etokimab(3)
  171. Etrolizumab(3)
  172. F16(10)
  173. Faricimab(2)
  174. FD441.8(10)
  175. Fezakinumab(3)
  176. Fletikumab(3)
  177. Fontolizumab(3)
  178. Fremanezumab(3)
  179. Fresolimumab(3)
  180. Frexalimab(3)
  181. G28-8(10)
  182. G544(10)
  183. G6(2)
  184. GAL-F2(2)
  185. Galcanezumab(3)
  186. Gatipotuzumab(3)
  187. Gevokizumab(3)
  188. Golimumab(3)
  189. GSK679586(3)
  190. Gumokimab(3)
  191. Guselkumab(3)
  192. H2L6(3)
  193. H398(10)
  194. H4H10(2)
  195. H5(10)
  196. H52(2)
  197. H6(20)
  198. HB 9579(10)
  199. HFE7A(10)
  200. HM1.24(10)
  201. hMAK195(3)
  202. HMBD-004A(2)
  203. HMBD-004B(2)
  204. HMFG1(10)
  205. HMPL-a83(2)
  206. hRFB4(2)
  207. HuGAL-F2(3)
  208. hum12G8(2)
  209. HuMax-IL15(3)
  210. huS6F1(2)
  211. HW1(10)
  212. IMA-026(3)
  213. IMC-002(2)
  214. IMC-1C11(2)
  215. ImClone 6.64(3)
  216. IMM01(2)
  217. Immurait-Ll2Mab(3)
  218. Inbakicept(2)
  219. Infliximab(3)
  220. Inolimomab(3)
  221. Inotuzumab(3)
  222. Itepekimab(3)
  223. Iv0058(4)
  224. Ivonescimab(2)
  225. Ixekizumab(3)
  226. JCAR018(2)
  227. JES6-1A12(4)
  228. KHK2866(3)
  229. L117/1(2)
  230. L120/12(2)
  231. L120/30(2)
  232. L19-TNF(3)
  233. Latikafusp(2)
  234. LDP-01(2)
  235. Lebrikizumab(3)
  236. Lemzoparlimab(3)
  237. Lenercept(2)
  238. Letaplimab(3)
  239. Letolizumab(2)
  240. Lexatumumab(3)
  241. Licaminlimab(2)
  242. Ligufalimab(3)
  243. Livmoniplimab(2)
  244. LL2(10)
  245. Lutikizumab(2)
  246. LY2525623(3)
  247. LY3016859(2)
  248. M1295(3)
  249. M17/4(12)
  250. M3A1(2)
  251. M3B8(2)
  252. M971(3)
  253. M972(3)
  254. Mab1(10)
  255. Magrolimab(3)
  256. Manfidokimab(3)
  257. Mapatumumab(3)
  258. MEDI 5117(3)
  259. MEDI2045(3)
  260. MEDI3185(2)
  261. MEDI3622(2)
  262. Mepolizumab(3)
  263. Metelimumab(3)
  264. MIAP410(2)
  265. Mirikizumab(3)
  266. MO82(2)
  267. MOR101(2)
  268. MOR102(2)
  269. Moxetumomab(2)
  270. MP5-20F3(2)
  271. MR-1(2)
  272. MR1/MR-1(10)
  273. N178A/9(2)
  274. N212/17(2)
  275. N212/7(2)
  276. N275/14(2)
  277. N295B/66(2)
  278. N324/2(2)
  279. N384/63(2)
  280. N39B/8(2)
  281. N4/15(2)
  282. N4/49(2)
  283. N83/48(2)
  284. Nacolomab(2)
  285. Natalizumab(3)
  286. Navicixizumab(2)
  287. Neihulizumab(3)
  288. Nerelimomab(3)
  289. Netakimab(3)
  290. NI-1701(2)
  291. NIS793(3)
  292. NOK1/NOK-1(10)
  293. NOK2/NOK-2(10)
  294. Odulimomab(3)
  295. Olamkicept(2)
  296. Olinvacimab(3)
  297. Olokizumab(3)
  298. Ontamalimab(3)
  299. Ontorpacept(2)
  300. Opinercept(2)
  301. OV52.24(10)
  302. Ozoralizumab(2)
  303. P4D2(10)
  304. Pankomab(3)
  305. Parsatuzumab(3)
  306. Pascolizumab(3)
  307. Pateclizumab(3)
  308. PC-61.5.3(2)
  309. PC61/PC61.5.3(10)
  310. Pemtumomab(2)
  311. Perakizumab(3)
  312. PF-03475952(2)
  313. Pinatuzumab(3)
  314. Placulumab(2)
  315. Pritumumab(3)
  316. PS/2(2)
  317. PTX25(10)
  318. Pulocimab(2)
  319. R310(2)
  320. R4-6A2(2)
  321. R6N(10)
  322. RA8(2)
  323. Rademikibart(3)
  324. Radretumab(2)
  325. Ramucirumab(3)
  326. Ranibizumab(2)
  327. REGN1909(2)
  328. Remtolumab(2)
  329. Reslizumab(3)
  330. RFB-4(10)
  331. RG7356(2)
  332. Rilonacept(2)
  333. Risankizumab(3)
  334. RO5458640(3)
  335. RO7296682(2)
  336. Romilkimab(2)
  337. Rovelizumab(2)
  338. Rozipafusp alfa(2)
  339. RTX-003(2)
  340. RTX-CD47(2)
  341. Ruplizumab(3)
  342. S4B6(2)
  343. S4B6-1(2)
  344. SAA0004(20)
  345. SAA0008(10)
  346. SAA0019(10)
  347. SAA0020(10)
  348. SAA0025(10)
  349. SAA0026(10)
  350. SAA0040(10)
  351. SAA0046(10)
  352. SAA0047(10)
  353. SAA0065(10)
  354. SAA0067(10)
  355. SAA0068(10)
  356. SAA0075(10)
  357. SAA0079(10)
  358. SAA0080(10)
  359. SAA0081(10)
  360. SAA0083(10)
  361. SAA0084(10)
  362. SAA0085(10)
  363. SAA0112(10)
  364. SAA0147(10)
  365. SAA0173(10)
  366. SAA0196(2)
  367. SAA0239(2)
  368. SAA0266(2)
  369. SAA0281(2)
  370. SAA0309(2)
  371. SAA0312(10)
  372. SAA0366(10)
  373. SAA0367(10)
  374. SAA0368(10)
  375. SAA0369(10)
  376. SAA0370(10)
  377. SAA0371(10)
  378. SAA0372(10)
  379. SAA0373(10)
  380. SAA0374(10)
  381. SAA0375(10)
  382. SAA0377(10)
  383. SAA0378(10)
  384. SAA0381(10)
  385. SAA0382(10)
  386. SAA0383(10)
  387. SAA0384(10)
  388. SAA0386(10)
  389. SAA0387(10)
  390. SAA0389(10)
  391. SAA0390(10)
  392. SAA0391(10)
  393. SAA0392(10)
  394. SAA0393(10)
  395. SAA0394(10)
  396. SAA0395(10)
  397. SAA0414(10)
  398. SAA0415(10)
  399. SAA0416(10)
  400. SAA0421(10)
  401. SAA0423(10)
  402. SAA0432(10)
  403. SAA0436(10)
  404. SAA0437(10)
  405. SAA0440(10)
  406. SAA0442(10)
  407. SAA0443(10)
  408. SAA0446(10)
  409. SAA0447(10)
  410. SAA0453(10)
  411. SAA0483(10)
  412. SAA0511(10)
  413. SAA0513(10)
  414. SAA0549(10)
  415. SAA0763(10)
  416. SAA0768(2)
  417. SAA0806(10)
  418. SAA0815(10)
  419. SAA1383(10)
  420. SAA1403(10)
  421. SAA1413(10)
  422. SAA1487(10)
  423. SAA1992(10)
  424. SAA2157(10)
  425. SAA2180(10)
  426. SAA2212(10)
  427. SAA2216(10)
  428. SAA2219(10)
  429. SAR-566658(2)
  430. SAR113244(3)
  431. SAR428926(3)
  432. sB24M(2)
  433. Secukinumab(3)
  434. SG404(2)
  435. SGN CD47M(2)
  436. Sibeprenlimab(3)
  437. Siltuximab(3)
  438. Simridarlimab(2)
  439. Sirukumab(3)
  440. SM06(2)
  441. SM3(2)
  442. Sontuzumab(3)
  443. SRF231(2)
  444. SRK-181(3)
  445. SSS-23(10)
  446. ST2146(10)
  447. Stapokibart(3)
  448. STI-003(2)
  449. STI-6643(2)
  450. Suciraslimab(2)
  451. SWA11(10)
  452. T24/31(10)
  453. TAB004(2)
  454. Tabalumab(3)
  455. Tanibirumab(2)
  456. Tarcocimab(2)
  457. TAS266(4)
  458. TAY018(2)
  459. Temtokibart(3)
  460. Tenatumomab(2)
  461. TI-061(2)
  462. Tibulizumab(2)
  463. Tigatuzumab(3)
  464. Tildrakizumab(3)
  465. Tilogotamab(3)
  466. TJ-C4GM(2)
  467. Toralizumab(2)
  468. Torudokimab(3)
  469. Tozorakimab(3)
  470. TQB 2928(2)
  471. Tralokinumab(3)
  472. TTI-621(2)
  473. TTI-622(2)
  474. Tulisokibart(3)
  475. Ulocuplumab(3)
  476. Urabrelimab(3)
  477. Ustekinumab(3)
  478. VAK-694(2)
  479. Vanucizumab(2)
  480. Varisacumab(3)
  481. VB6(10)
  482. VB6-008(2)
  483. Vedolizumab(3)
  484. VFF-18(10)
  485. VGX100(3)
  486. VIS-649(10)
  487. Vopikitug(3)
  488. Vulinacimab(3)
  489. Vunakizumab(3)
  490. Vx-1004(2)
  491. Xeligekimab(2)
  492. Xentuzumab(3)
  493. XmAb 5592(3)
  494. XMG1.2(4)
  495. XOMA 089(2)
  496. XT3.11(2)
  497. YT33(2)
  498. Ziltivekimab(3)
  499. ZL-1201(2)
Applications
Isotype

Cell Biology

5419 Artikel

pro Seite

Seite:
  1. 64
  2. 65
  3. 66
  4. 67
  5. 68
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Research Grade Bevacizumab Biosimilars Bevacizumab Hu ANSY-DHD12602-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Siltuximab Biosimilars Siltuximab Hu ANSY-DHC15801-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Vedolizumab Biosimilars Vedolizumab Hu ANSY-DHC98802-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Mepolizumab Biosimilars Mepolizumab Hu ANSY-DHC13602-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Reslizumab Biosimilars Reslizumab Hu ANSY-DHC13601-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Galcanezumab Biosimilars Galcanezumab Hu ANSY-DHC22401-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Brolucizumab Brolucizumab Hu ANSY-DHD12603-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Eptinezumab Biosimilars Eptinezumab Hu ANSY-DHC22403-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human IL15 (DISC0280) Antibody Monoclonal DISC0280 Hu Human ANSY-DHE28303-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Depemokimab Biosimilars Depemokimab Hu ANSY-DHC13603-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human IL10 (MK-­1966) Antibody Monoclonal MK-1966 Hu Human ANSY-DHD50703-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human IL10 (SCH708980) Antibody Monoclonal SCH708980 Hu Human ANSY-DHD50704-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Tarcocimab Tarcocimab Hu ANSY-DHD12606-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Burfiralimab Burfiralimab Hu ANSY-DHC35302-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human VEGFA Antibody (BD0801) Antibody Monoclonal BD0801 Hu Human ANSY-DHD12607-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human Hypo-­glycosylated MUC1 Antibody (TAB004) Antibody Monoclonal TAB004 Hu ANSY-DHD14208-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human IL4 Antibody (25D2) Antibody Monoclonal 25D2 Hu Human ANSY-DHC13503-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Pemtumomab Pemtumomab Hu Mouse ANSY-DHD14209-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Sonelokimab Sonelokimab Hu ANSY-DHH28808-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Magrolimab Biosimilars Magrolimab Hu ANSY-DHG17601-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human CD279/­PDCD1/­PD1 & IL2 (IBI363) Antibody Monoclonal IBI363 Hu Human ANSY-DHH02240-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Neihulizumab Biosimilars Neihulizumab Hu ANSY-DHG76501-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human IL17A (ABM59) Antibody Monoclonal ABM59 Hu Human ANSY-DHH28813-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human IL17A (CAT-­2200) Antibody Monoclonal CAT-2200 Hu Human ANSY-DHH28814-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human IL17A (CNTO-­6785) Antibody Monoclonal CNTO-6785 Hu Human ANSY-DHH28815-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Name Preis
Research Grade Bevacizumab Anmelden Research Grade Bevacizumab
Typ Biosimilars
Clone Bevacizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Siltuximab Anmelden Research Grade Siltuximab
Typ Biosimilars
Clone Siltuximab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Vedolizumab Anmelden Research Grade Vedolizumab
Typ Biosimilars
Clone Vedolizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Mepolizumab Anmelden Research Grade Mepolizumab
Typ Biosimilars
Clone Mepolizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Reslizumab Anmelden Research Grade Reslizumab
Typ Biosimilars
Clone Reslizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Galcanezumab Anmelden Research Grade Galcanezumab
Typ Biosimilars
Clone Galcanezumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Brolucizumab Anmelden Research Grade Brolucizumab
Typ
Clone Brolucizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Eptinezumab Anmelden Research Grade Eptinezumab
Typ Biosimilars
Clone Eptinezumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human IL15 (DISC0280) Anmelden Research Grade Anti-Human IL15 (DISC0280)
Typ Antibody Monoclonal
Clone DISC0280
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Depemokimab Anmelden Research Grade Depemokimab
Typ Biosimilars
Clone Depemokimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human IL10 (MK-­1966) Anmelden Research Grade Anti-Human IL10 (MK-1966)
Typ Antibody Monoclonal
Clone MK-1966
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human IL10 (SCH708980) Anmelden Research Grade Anti-Human IL10 (SCH708980)
Typ Antibody Monoclonal
Clone SCH708980
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Tarcocimab Anmelden Research Grade Tarcocimab
Typ
Clone Tarcocimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Burfiralimab Anmelden Research Grade Burfiralimab
Typ
Clone Burfiralimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human VEGFA Antibody (BD0801) Anmelden Research Grade Anti-Human VEGFA Antibody (BD0801)
Typ Antibody Monoclonal
Clone BD0801
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human Hypo-­glycosylated MUC1 Antibody (TAB004) Anmelden Research Grade Anti-Human Hypo-glycosylated MUC1 Antibody (TAB004)
Typ Antibody Monoclonal
Clone TAB004
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human IL4 Antibody (25D2) Anmelden Research Grade Anti-Human IL4 Antibody (25D2)
Typ Antibody Monoclonal
Clone 25D2
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Pemtumomab Anmelden Research Grade Pemtumomab
Typ
Clone Pemtumomab
Specific against Hu
Appl.
Host Mouse
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Sonelokimab Anmelden Research Grade Sonelokimab
Typ
Clone Sonelokimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Magrolimab Anmelden Research Grade Magrolimab
Typ Biosimilars
Clone Magrolimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human CD279/­PDCD1/­PD1 & IL2 (IBI363) Anmelden Research Grade Anti-Human CD279/PDCD1/PD1 & IL2 (IBI363)
Typ Antibody Monoclonal
Clone IBI363
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Neihulizumab Anmelden Research Grade Neihulizumab
Typ Biosimilars
Clone Neihulizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human IL17A (ABM59) Anmelden Research Grade Anti-Human IL17A (ABM59)
Typ Antibody Monoclonal
Clone ABM59
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human IL17A (CAT-­2200) Anmelden Research Grade Anti-Human IL17A (CAT-2200)
Typ Antibody Monoclonal
Clone CAT-2200
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human IL17A (CNTO-­6785) Anmelden Research Grade Anti-Human IL17A (CNTO-6785)
Typ Antibody Monoclonal
Clone CNTO-6785
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar

5419 Artikel

pro Seite

Seite:
  1. 64
  2. 65
  3. 66
  4. 67
  5. 68
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top